News Red Havas launches 'global health micro-network' Red Havas has announced the launch of Red Havas Health, a global micro-network focused on health, in response to increasing demand from clients globally.
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face